Details for New Drug Application (NDA): 207797
✉ Email this page to a colleague
The generic ingredient in RIVASTIGMINE TARTRATE is rivastigmine tartrate. There are thirty-two drug master file entries for this compound. Thirteen suppliers are listed for this compound. Additional details are available on the rivastigmine tartrate profile page.
Summary for 207797
Tradename: | RIVASTIGMINE TARTRATE |
Applicant: | Chartwell Rx |
Ingredient: | rivastigmine tartrate |
Patents: | 0 |
Pharmacology for NDA: 207797
Mechanism of Action | Cholinesterase Inhibitors |
Suppliers and Packaging for NDA: 207797
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
RIVASTIGMINE TARTRATE | rivastigmine tartrate | CAPSULE;ORAL | 207797 | ANDA | Chartwell RX, LLC | 62135-900 | 62135-900-60 | 60 CAPSULE in 1 BOTTLE (62135-900-60) |
RIVASTIGMINE TARTRATE | rivastigmine tartrate | CAPSULE;ORAL | 207797 | ANDA | Chartwell RX, LLC | 62135-901 | 62135-901-60 | 60 CAPSULE in 1 BOTTLE (62135-901-60) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | CAPSULE;ORAL | Strength | EQ 1.5MG BASE | ||||
Approval Date: | Sep 28, 2017 | TE: | AB | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | RX | Dosage: | CAPSULE;ORAL | Strength | EQ 3MG BASE | ||||
Approval Date: | Sep 28, 2017 | TE: | AB | RLD: | No |
Profile for product number 003
Active Rx/OTC/Discontinued: | RX | Dosage: | CAPSULE;ORAL | Strength | EQ 4.5MG BASE | ||||
Approval Date: | Sep 28, 2017 | TE: | AB | RLD: | No |
Complete Access Available with Subscription